Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT07170917

Public ClinicalTrials.gov record NCT07170917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study of Brivekimig Followed by a Maintenance Period in Participants With Moderate to Severe Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of the main study is to assess the efficacy and safety of brivekimig in a dose-ranging study of participants with moderate to severe HS. Study details include: The study duration (per participant) will be up to approximately 164 weeks for participants transitioning into the long-term extension (LTE) period and will be up to approximately 60 weeks for participants not transitioning into the LTE period. The randomized treatment duration will be up to approximately 152 weeks

Study identification

NCT ID
NCT07170917
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
208 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2025 (Actual)
Primary completion
Feb 9, 2027 (Estimated)
Completion
Nov 23, 2029 (Estimated)
Last update posted
Oct 14, 2026

2025 – 2029

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Medical Dermatology Specialists- Site Number : 8400019 Phoenix Arizona 85006 Recruiting
Mayo Clinic in Arizona - Scottsdale- Site Number : 8400014 Scottsdale Arizona 85259 Recruiting
Northridge Clinical Trials - Northridge- Site Number : 8400005 Northridge California 91325 Recruiting
Beth Israel Deaconess Medical Center - Fort Myers- Site Number : 8400001 Fort Myers Florida 33919 Recruiting
FXM Clinical Research - Miami- Site Number : 8400017 Miami Florida 33175 Recruiting
FXM Clinical Research - Miramar- Site Number : 8400004 Miramar Florida 33027 Recruiting
Advanced Medical Research - Atlanta- Site Number : 8400011 Atlanta Georgia 30342 Recruiting
Georgia Skin & Cancer Clinic- Site Number : 8400009 Savannah Georgia 31419 Recruiting
The Iowa Clinic West Des Moines Campus- Site Number : 8400007 West Des Moines Iowa 50266 Recruiting
Louisiana Dermatology Associates- Site Number : 8400006 Baton Rouge Louisiana 70809 Recruiting
Washington University- Site Number : 8400010 St Louis Missouri 63110 Recruiting
JDR Dermatology Research- Site Number : 8400012 Las Vegas Nevada 89145 Recruiting
Icahn School of Medicine at Mount Sinai- Site Number : 8400021 New York New York 10029 Recruiting
University of North Carolina at Chapel Hill- Site Number : 8400025 Chapel Hill North Carolina 27514 Recruiting
Clinical Partners- Site Number : 8400002 Johnston Rhode Island 02919 Recruiting
AMR Clinical South Strand, South Carolina- Site Number : 8400018 Myrtle Beach South Carolina 29588 Recruiting
Ut Southwestern Medical Center, Department Of Dermatology- Site Number : 8400022 Dallas Texas 75235 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07170917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07170917 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →